publications - HUB Organoids

February 16, 2022

A Living Biobank of Breast Cancer Organoids Captures Disease Heterogeneity

Cell | Jan 2018

February 16, 2022

Long-term culture, genetic manipulation and xenotransplantation of human normal and breast cancer organoids

Nat Protoc | April 2021

February 16, 2022

G970R-CFTR Mutation (c.2908G>C) Results Predominantly in a Splicing Defect

Clin Transl Sci | March 2021

February 16, 2022

Lumacaftor/ivacaftor in people with cystic fibrosis with an A455E-CFTR mutation

J Cyst Fibros | Sep 2021 | Clinical trial

February 16, 2022

Rectal Organoids Enable Personalized Treatment of Cystic Fibrosis

Cell Rep | February 2019

February 16, 2022

Sequential cancer mutations in cultured human intestinal stem cells

Nature | May 2015

February 16, 2022

Functional patient-derived organoid screenings identify MCLA-158 as a therapeutic EGFR × LGR5 bispecific antibody with efficacy in epithelial tumors

Nat Cancer | April 2022

February 16, 2022

Molecular and Functional Characterization of Human Intestinal Organoids and Monolayers for Modeling Epithelial Barrier

Inflamm Bowel Dis | Nov 2022

February 16, 2022

Long-term expanding human airway organoids for disease modeling

EMBO J | February 2019

February 16, 2022

Patient-derived organoids as a predictive biomarker for treatment response in cancer patients

NPJ Precis Oncol | April 2021

HUB Organoids

Resources

A Living Biobank of Breast Cancer Organoids Captures Disease Heterogeneity

Long-term culture, genetic manipulation and xenotransplantation of human normal and breast cancer organoids

G970R-CFTR Mutation (c.2908G>C) Results Predominantly in a Splicing Defect

Lumacaftor/ivacaftor in people with cystic fibrosis with an A455E-CFTR mutation

Rectal Organoids Enable Personalized Treatment of Cystic Fibrosis

Sequential cancer mutations in cultured human intestinal stem cells

Functional patient-derived organoid screenings identify MCLA-158 as a therapeutic EGFR × LGR5 bispecific antibody with efficacy in epithelial tumors

Molecular and Functional Characterization of Human Intestinal Organoids and Monolayers for Modeling Epithelial Barrier

Long-term expanding human airway organoids for disease modeling

Patient-derived organoids as a predictive biomarker for treatment response in cancer patients

Have any questions?